Interesting facts
Interesting Facts about 3-[3-[5-[5-(4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl)oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one
This compound represents a fascinating example of complex organic chemistry and illustrates the intricate relationships found within natural products. Its structure features multiple functional groups and stereocenters, showcasing not only the diversity of organic compounds but also the potential for intricate biosynthesis in living organisms.
Key Highlights of the Compound:
- Natural Source: Compounds of this complexity often derive from plant secondary metabolites, which play critical roles in plant defense mechanisms and interactions with other organisms.
- Biological Activity: Some compounds with furan-5-one and tetrahydropyran structures have been studied for their potential medicinal properties, such as anti-inflammatory and antioxidant effects.
- Synthesis Challenge: The synthesis of such large, multi-ring compounds is a significant challenge in organic chemistry, requiring advanced techniques in both synthetic and analytical chemistry.
- Research Interest: Scientists are continually exploring these types of compounds for their applications in pharmaceuticals, which can include developing new drugs and understanding biological pathways.
As the chemist Robert H. Grubbs once said, “Chemistry is the essence of life.” This compound exemplifies how complex structures contribute to life’s diversity, reflecting the beauty and intricacy of the molecular world. The study of such compounds not only illuminates their function and mechanism but also inspires future innovations in both chemistry and biology.
Synonyms
Lanicor
Cogoxin
Digitalis glycoside
3-[3-[5-[5-(4,5-dihydroxy-6-methyloxan-2-yl)oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one
Lanacordin
Lenoxin
NSC95100
Lanoxine-PG
3-(3-(5-(5-(4,5-dihydroxy-6-methyloxan-2-yl)oxy-4-hydroxy-6-methyloxan-2-yl)oxy-4-hydroxy-6-methyloxan-2-yl)oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta(a)phenanthren-17-yl)-2H-furan-5-one
3-{[2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide
12.beta.-Hydroxydigitoxin
CHEMBL20692
SCHEMBL126382
DTXSID10860258
LTMHDMANZUZIPE-UHFFFAOYSA-N
BBL033712
STL372822
AKOS025247958
NCGC00248443-01
VS-12230
DB-045400
D6003
AP-163/40806811
1380169-08-3
3-((2,6-Dideoxy-4-O-[2,6-dideoxy-4-O-(2,6-dideoxyhexopyranosyl)hexopyranosyl]hexopyranosyl)oxy)-12,14-dihydroxycard-20(22)-enolide, (3.beta.,5.beta.,12.beta.)- #
3-[(O-2,6-Dideoxyhexopyranosyl-(1a4)-O-2,6-dideoxyhexopyranosyl-(1a4)-2,6-dideoxyhexopyranosyl)oxy]-12,14-dihydroxycard-20(22)-enolide
3.beta.-[(O-2,6-Dideoxy-.beta.-D-ribo-hexopyranosyl-(1.->.4)-O-2,6-dideoxy-.beta.-D-ribo-hexopyranosyl-(1.->.4)-2,6-dideoxy-.beta.-D-ribo-hexopyranosyl)oxy]-12.beta.,14-dihydroxy-5.beta.-card-20(22)-enolide
4-(3-((5-((5-((4,5-dihydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-4-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-4-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-12,14-dihydroxy-10,13-dimethylhexadecahydro-1h-cyclopenta[a]phenanthren-17-yl)furan-2(5h)-one
4-(7-{[5-({5-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-4-hydroxy-6-methyloxan-2-yl}oxy)-4-hydroxy-6-methyloxan-2-yl]oxy}-3a,11-dihydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl)-2,5-dihydrofuran-2-one
Card-20(22)-enolide, 3-((O-2,6-dideoxy-.beta.-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-.beta.-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-.beta.-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3.beta.,5.beta.,12.beta.)-
Card-20(22)-enolide, 3-[(O-2,6-dideoxy-.beta.-D-ribo-hexopyranosyl-(1->4)-O-2,6-dideoxy-.beta.-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-.beta.-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxy-, (3.beta.,5.beta.,12.beta.)-
Card-20(22)-enolide, 3-[(O-2,6-dideoxy-.beta.-D-ribo-hexopyranosyl-(1.->.4)-O-2,6-dideoxy-.beta.-D-ribo-hexopyranosyl-(1.->.4)-2,6-dideoxy-.beta.-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxy-, (3.beta.,5.beta.,12.beta.)-
Solubility of 3-[3-[5-[5-(4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl)oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one (C41H64O13)
The solubility of the compound 3-[3-[5-[5-(4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl)oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one can be quite complex due to its highly intricate structure. Here are some key points to consider:
In summary, while the polar nature of the multiple hydroxyl groups suggests favorable interactions with polar solvents, the extensive and complex hydrophobic parts of the molecule may hinder complete solubility, leading to a nuanced and solvent-dependent solubility profile.